Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04465864 · ClinicalTrials.gov registry record · Phase 4
Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert
A Phase 4 study of Cataract and Glaucoma, Primary Open Angle, sponsored by Wolstan and Goldberg Eye Associates.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04465864: Completed Phase 4 study of Cataract and Glaucoma, Primary Open Angle, sponsored by Wolstan and Goldberg Eye Associates.
NCT04465864 is a Phase 4 study of Cataract and Glaucoma, Primary Open Angle that has completed, run by Wolstan and Goldberg Eye Associates. The registered enrollment target is 40 participants, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04465864, a Phase 4 study of Cataract and Glaucoma, Primary Open Angle, has completed, sponsored by Wolstan and Goldberg Eye Associates.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized, controlled treatment with an intracanalicular dexamethasone (0.4mg) insert following cataract surgery with intraocular lens implant (IOL) combined with minimally invasive glaucoma surgery (MIGS), specifically iStent, iStent inject or KDB in patients with primary open angle glaucoma (POAG) or ocular hypertension (OHTN)
Primary Outcome
Primary: Will receive the insert four days (+/- 1 day) prior to surgery. Each enrolled subject will be required to complete seven scheduled visits over the course of the study period: Baseline, insertion visit, operative visit, Day 1, 7, 30, and a 14 \& 45-day phone call. Absence of cells in anterior chamber at day 7 as measured by: Summed Ocular Inflammation Score (0-4) Absence of cell to be defined as a grade of (0-0.5) Absence of pain at Day 7 (score of 0) as measured by ocular pain assessme
Conditions Studied
Interventions
- DRUG Intracanalicular Dexamethasone, 0.4 mg insert
Study Locations (1)
California
- Wolstan and Goldberg Eye Associates - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-02-10 |
| Est. Completion | 2021-01-31 |
| Phase | Phase 4 |
What the finished NCT04465864 record still lists
NCT04465864 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 228-participant average among 83 other Cataract trials with a reported enrollment target (82% lower).
The record links to 2 conditions, with Cataract appearing as the primary indexed condition, and to 1 intervention - of which Intracanalicular Dexamethasone, 0.4 mg insert is the first listed.
NCT04465864 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04465864 about?
NCT04465864 is a clinical study titled "Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert". Randomized, controlled treatment with an intracanalicular dexamethasone (0.4mg) insert following cataract surgery with intraocular lens implant (IOL) combined with minimally invasive glaucoma surgery (MIGS), specifically iStent, iStent inject or KDB in patients with primary open angle glaucoma (POAG...
What is the current status of trial NCT04465864?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2020-02-10. Estimated completion is 2021-01-31.
What conditions does trial NCT04465864 study?
This clinical trial studies the following conditions: Cataract, Glaucoma, Primary Open Angle.
What interventions are being tested in trial NCT04465864?
The interventions under investigation include: Intracanalicular Dexamethasone, 0.4 mg insert (DRUG).
Who is sponsoring clinical trial NCT04465864?
This trial is sponsored by Wolstan and Goldberg Eye Associates, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04465864 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cataract
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04465864's enrollment target sits among peer trials
40 65th of 83 higher than 14 of 83 other Cataract trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cataract trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
RECRUITING · Phase 4
-
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
RECRUITING · Phase 4
-
Evaluation of a Monofocal Intraocular Lens
RECRUITING · Phase 4
-
Evaluate the Safety of DEXYCU for the Treatment of Inflammation Following Ocular Surgery for Childhood Cataract
RECRUITING · Phase 4
-
Odyssey Evaluation in Post LASIK Patients
RECRUITING · Phase 4
-
Dropless vs. Standard Drops Contralateral Eye Study
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI